Safety and Clinical Activity of ThisCART22 in Patients With r/r Non-Hodgkin's B Cell Lymphoma

Clinical trial NCT05106946 · UNKNOWN

Trial details

NCT number: NCT05106946
Sponsor: Fundamenta Therapeutics, Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

B-cell Malignancy

Start date: 2021-10-25
Primary completion: 2023-10-25
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.